Third-generation oral contraceptives are an association of low-dose ethinyl estradiol and potent testosterone-derived progestins, developed in order to improve general and vascular tolerance.
Generating solid stock market gains can be daunting for younger investors or those on a tight budget because many top technology stocks trade anywhere from $25 to over $100 per share and much more.